By Topic

Analyzing the Symptoms in Cancer Patients [Chronobiological Investigations]

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

1 Author(s)
Rich, T.A. ; Univ. of Virginia, Charlottesville

In summary, the recent increase in the knowledge of the signaling mechanisms in the circadian axis along with a fuller understanding of the interaction of the epidermal growth factor receptor (EGFR) family of ligands and how they can interact with the brain have led to a new hypothesis that the symptom complex of fatigue, poor appetite, and sleep disruption in cancer patients are related to altered hypothalamic circadian signaling. These early observations are being tested further, and in the near future may also guide therapeutic interventions in selected cancer patients with anti-EGFR therapies for the explicit use for managing common side effects.

Published in:

Engineering in Medicine and Biology Magazine, IEEE  (Volume:27 ,  Issue: 1 )